Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stratifin as a novel diagnostic biomarker in serum for diffuse alveolar damage.
Arakawa N, Ushiki A, Abe M, Matsuyama S, Saito Y, Kashiwada T, Horimasu Y, Gemma A, Tatsumi K, Hattori N, Tsushima K, Miyashita K, Saito K, Nakamura R, Toyoda T, Ogawa K, Sato M, Takamatsu K, Mori K, Nishiya T, Izumi T, Ohno Y, Saito Y, Hanaoka M. Arakawa N, et al. Among authors: kashiwada t. Nat Commun. 2022 Oct 4;13(1):5854. doi: 10.1038/s41467-022-33160-9. Nat Commun. 2022. PMID: 36195613 Free PMC article.
XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts.
Kamio K, Azuma A, Usuki J, Matsuda K, Inomata M, Nishijima N, Itakura S, Hayashi H, Kashiwada T, Kokuho N, Atsumi K, Yamaguchi T, Fujita K, Saito Y, Abe S, Kubota K, Gemma A. Kamio K, et al. Among authors: kashiwada t. Pulm Pharmacol Ther. 2017 Jun;44:61-69. doi: 10.1016/j.pupt.2017.03.003. Epub 2017 Mar 14. Pulm Pharmacol Ther. 2017. PMID: 28315487
Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression.
Tozuka T, Seike M, Minegishi Y, Kitagawa S, Kato T, Takano N, Hisakane K, Takahashi S, Kobayashi K, Kashiwada T, Sugano T, Takeuchi S, Kunugi S, Noro R, Saito Y, Kubota K, Gemma A. Tozuka T, et al. Among authors: kashiwada t. Onco Targets Ther. 2018 Sep 7;11:5601-5605. doi: 10.2147/OTT.S168598. eCollection 2018. Onco Targets Ther. 2018. PMID: 30237726 Free PMC article.
A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab.
Sugano T, Seike M, Noro R, Kaburaki S, Tozuka T, Takahashi A, Takano N, Tanaka T, Kashiwada T, Takeuchi S, Minegishi Y, Saito Y, Kubota K, Terasaki Y, Gemma A. Sugano T, et al. Among authors: kashiwada t. Onco Targets Ther. 2018 Sep 17;11:5879-5883. doi: 10.2147/OTT.S169321. eCollection 2018. Onco Targets Ther. 2018. PMID: 30271171 Free PMC article.
Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravis.
Tozuka T, Sugano T, Noro R, Takano N, Hisakane K, Takahashi S, Tanaka T, Kashiwada T, Takeuchi S, Kunugi S, Minegishi Y, Saito Y, Kubota K, Seike M, Gemma A. Tozuka T, et al. Among authors: kashiwada t. Oxf Med Case Reports. 2018 Oct 22;2018(11):omy094. doi: 10.1093/omcr/omy094. eCollection 2018 Nov. Oxf Med Case Reports. 2018. PMID: 30364514 Free PMC article.
69 results